Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High?

MBX Biosciences, Inc. (MBX) closed the last trading session at $24.07, gaining 74.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 58.25 indicates a 142% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $16.63. While the lowest estimate of$ 30.00 indicates a 24.6% increase from the current price level, the most optimistic a ...